NASDAQ:LGVN

Longeveron Stock Predictions

etoro logo Buy LGVN
*Your capital is at risk
$0.80
+0.0400 (+5.26%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

LGVN Prediction Chart

LGVN Predictions History

Latest community submissions for LGVN.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 13, 2026 $0.768 -5.08% $0.97 X 78.88% 0
Mar 13, 2026 $0.783 -3.17% $0.97 X 80.46% 0
Mar 13, 2026 Bearish $0.97 X 0
Jan 28, 2026 $0.563 -2.86% $0.594 X 94.75% 0
Jan 28, 2026 $0.569 -1.79% $0.594 X 95.80% 0
Jan 28, 2026 $1.00 +72.56% $0.594 V 31.68% 1
Dec 18, 2025 $0.577 -3.16% $0.551 V 95.28% 1
Dec 18, 2025 $0.608 +1.97% $0.551 X 89.74% 0
Dec 18, 2025 Bullish $0.551 X 0
Jul 3, 2025 $15.00 +1 053.85% Unrealistic Excluded from avg $1.31 V 0.00% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LGVN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT LONGEVERON INC.
Longeveron
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE